Thanks to this 100% online Professional master’s degree, you will acquire advanced skills and critical knowledge for the management of pediatric patients in emergency and intensive care situations"

Pediatric Intensive Care Medicine has experienced significant advances in recent years, driven by the development of new technologies and innovative therapeutic approaches. Currently, it focuses on the personalization of treatment, using advanced monitoring tools and life support techniques that improve accuracy in the care of critically ill patients. 
In this context, this Professional master’s degree in Professional master’s degree is presented, a program designed to provide physicians with the necessary competencies to offer specialized care in the Pediatric Intensive Care Unit (PICU) of any hospital center. Therefore, it has been structured in ten modules, focused on the theoretical knowledge and practical skills essential for the management of the most complex pathologies affecting pediatric patients in critical situations. 

Therefore, throughout the program, essential topics will be developed, from advanced management of the airway and life support, to communication strategies with families and ethical decision making. The most advanced techniques and best practices in the treatment of critical conditions will also be addressed, as well as the latest advances in medical technology and pharmacology. Likewise, the multidisciplinary approach necessary for the integral care of patients will be emphasized. 

Finally, research and critical analysis will be studied in depth, preparing professionals to contribute to the advancement of Pediatric Intensive Care Medicine through innovation and continuous improvement of clinical practice. In addition, the syllabus will follow a logical sequence, allowing graduates to build their knowledge and skills progressively. 

At this juncture, TECH has designed a complete 100% online program, adapted to the individual needs of students, avoiding inconveniences such as traveling to a physical center or adjusting to a pre-established schedule. Additionally, it is supported by the innovative Relearning methodology, consisting of the repetition of key concepts for an optimal and organic assimilation of the contents.

You will be trained in the identification and management of infectious emergencies, Sepsis, and neurological and endocrinological conditions, along with an in-depth understanding of Neonatology. What are you waiting for to enroll?"

This Professional master’s degree in Pediatric Intensive Care Medicine contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Pediatric Intensive Care Medicine
• The graphic, schematic and eminently practical contents with which it is conceived gather scientific and practical information on those disciplines that are indispensable for professional practice 
• Practical exercises where self-assessment can be used to improve learning. 
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection

You will address assessment of nutritional needs and fluid management in critically ill children, recognizing pain as the fifth constant in Pediatrics. With all the TECH quality guarantees!"

The program’s teaching staff includes professionals from the field who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations. 

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will become familiar with the most advanced techniques of mechanical ventilation, hemodynamic monitoring and management of congenital heart disease, through the extensive library of multimedia resources offered by TECH"

Bet on TECH! You will gain profound pediatric neurological knowledge, promoting a comprehensive management from initial evaluation to long-term follow-up and family support"

This Professional master’s degree in Pediatric Intensive Care Medicine has a highly specialized study plan, which will cover critical and cutting-edge aspects of Pediatric Medicine, such as the management of rare and acute diseases, advanced resuscitation techniques and the application of genetic and cellular therapies in clinical practice. In addition, an interprofessional approach to learning will be incorporated, meaning that graduates will collaborate closely with experts in areas such as Pharmacology, Nutrition and Social Work to provide comprehensive care to the pediatric patient.

This Professional master’s degree in Pediatric Intensive Care Medicine has been designed to provide you with comprehensive and specialized specialization in the management of critically ill pediatric patients"

Module 1. Pediatric Intensive Care

1.1. Pediatric Intensive Care

1.1.1. Pediatric Physiology and Pathophysiology in the Context of Intensive Care
1.1.2. Pediatric and Adult Patients in the ICU Key Differences
1.1.3. Principles of Bioethics and Evidence-based Decision Making in the Pediatric Intensive Care Unit

1.2. Initial Assessment of the Critically Ill Pediatric Patient

1.2.1. Comprehensive and Systematic Assessment
1.2.2. Signs of Severity and Stabilization of Vital Functions
1.2.3. Prioritization of Interventions According to Immediate Clinical Needs

1.3. Airway Management in Pediatrics

1.3.1. Airway Patency and Ventilatory Management
1.3.2. Endotracheal Intubation and Management of Complications
1.3.3. Selection and Use of Noninvasive Airway Support Devices 

1.4. Monitoring in the Pediatric Intensive Care Unit

1.4.1. Implementation of Advanced Monitoring Techniques
1.4.2. Interpretation of Data to Adjust Patient Management
1.4.3. Monitoring Technologies to Improve Patient Safety 

1.5. Pediatric Intensive Care Pharmacology

1.5.1. Pharmacotherapy Management in Emergency and Intensive Care Situations
1.5.2. Pharmacokinetics and Pharmacodynamics in the Pediatric Patient
1.5.3. Identification and Management of Drug Interactions and Adverse Drug Effects

1.6. Nutrition in the Critically Ill Pediatric Patient

1.6.1. Assessment of Nutritional Status and Requirements in the Critically Ill Patient
1.6.2. Implementation of Enteral and Parenteral Nutrition Strategies 
1.6.3. Monitoring and Adjustment of Nutrition Based on Clinical Response

1.7. Ethical Aspects in Pediatric Intensive Care

1.7.1. Specific Ethical Dilemmas in Pediatric Intensive Care
1.7.2. Communicating Bad News in a Compassionate and Effective Manner
1.7.3. Participation in End-of-life Decisions and Palliative Care 

1.8. Communication with Families and Teamwork

1.8.1. Development of Communication Skills with Families During Stress 
1.8.2. Shared Decision Making with Caregivers
1.8.3. Team Approach to Interdisciplinary Care 

1.9. Prevention of Healthcare-associated Infections in the Pediatric Intensive Care Unit

1.9.1. Protective Barriers and Isolation
1.9.2. Appropriate Use of Antibiotics
1.9.3. Infection Surveillance and Control Strategies

1.10. Intrahospital Transport in the Pediatric Critically Ill Patient

1.10.1. Planning and Coordination
1.10.2. Equipment and Monitoring
1.10.3. Safety and Risk Minimization

Module 2. Respiratory Emergencies in the Pediatric Intensive Care Unit 

2.1. Acute Respiratory Failure

2.1.1. Gas Exchange Hypoxemia and Hypercapnia
2.1.2. Oxygenation Techniques
2.1.3. Respiratory Monitoring
2.1.4. Respiratory Therapies Heliox Nitric Oxide

2.2. Airway Management

2.2.1. Tracheal Intubation Rapid Intubation Sequence (RIS)
2.2.2. Difficult Airway
2.2.3. Tracheotomy and Cryostomy
2.2.4. Videolaryngoscopy and Bronchoscopy

2.3. Invasive Mechanical Ventilation

2.3.1. Respiratory Physiology
2.3.2. Ventilatory Modes
2.3.3. Programming of Mechanical Ventilation

2.4. Non-Invasive Mechanical Ventilation

2.4.1. General Information on NIV Material
2.4.2. NIV Programming
2.4.3. Programming Analysis

2.5. Bronchiolitis

2.5.1. Epidemiology
2.5.2. Pathophysiology
2.5.3. Treatment
2.5.4. Invasive and Non-Invasive Mechanical Ventilation
2.5.5. Obstructive and Restrictive Pattern

2.6. Asthmatic Status

2.6.1. Epidemiology
2.6.2. Pathophysiology
2.6.3. Treatment
2.6.4. Invasive and Non-Invasive Mechanical Ventilation
2.6.5. Aerial Entrapment

2.7. Pediatric Acute Respiratory Distress Syndrome (ARDS)

2.7.1. Epidemiology
2.7.2. Pathophysiology
2.7.3. Diagnosis. Differential Diagnosis
2.7.4. Treatment
2.7.5. Prognosis

2.8. Chronic Respiratory Diseases in Intensive Care

2.8.1. The Chronic and Complex Chronic Patient in PICU
2.8.2. Exacerbations of Chronic Respiratory Diseases
2.8.3. Care of the Tracheostomized Patient
2.8.4. Switching to Home Mechanical Ventilation
2.8.5. Complementary Treatments

2.9. Pleural Effusion Chylothorax. Pneumothorax

2.9.1. Pleural Effusion
2.9.2. Chylothorax
2.9.3. Pneumothorax
2.9.4. Drainage System: Use and Care

2.10. Pulmonary Hypertension Drowning Smoke Inhalation

2.10.1. Pulmonary Hypertension
2.10.2. Drowning
2. 10.3. Smoke Inhalation Hemodynamic Emergencies in the Pediatric Intensive Care Unit

Module 3. Hemodynamic Emergencies in the Pediatric Intensive Care Unit

3.1. Hemodynamic Monitoring in Pediatrics

3.1.1. Hemodynamic Monitoring in the Critically Ill Pediatric Patient
3.1.2. Interpretation of Hemodynamic Data for the Identification and Treatment of Cardiovascular Function Alterations
3.1.3. Evaluation of the Effectiveness of Therapeutic Interventions with Advanced Monitoring Techniques 

3.2. The Electrocardiogram (ECG) in Pediatrics

3.2.1. The Pediatric ECG Physiological Differences According to Age
3.2.2. Diagnosis of Electrolyte Disorders, Congenital Heart Disease and Cardiomyopathies through ECG Analysis
3.2.3. Management of Urgent Pediatric Arrhythmias based on ECG Presentation

3.3. Shock in Pediatrics: Early Recognition

3.3.1. Identification of Early Signs and Symptoms of Shock in Children for Rapid interventions
3.3.2. Shock in Pediatric Patients: Hypovolemic, Distributive, Cardiogenic, Obstructive
3.3.3. Hemodynamic Monitoring Parameters for Early Detection of Shock

3.4. Shock Management in Pediatrics

3.4.1. Evidence-based Resuscitation Protocols for the Treatment of Shock in Children
3.4.2. Use of Fluid Therapy, Inotropes and Vasopressors in the Management of Pediatric Shock
3.4.3. Assessment of Response to Treatment and Adjustment of Life Support Therapy according to the Individual Patient's Needs

3.5. Diagnosis of Heart Failure in Children

3.5.1. Use of Imaging Techniques and Biomarkers for Early Diagnosis of Heart Failure in Pediatrics
3.5.2. Acute and Chronic Heart Failure in Children: Clinical Manifestations
3.5.3. Underlying Causes of Heart Failure in the Pediatric Population for Appropriate Etiological Management

3.6. Management of Heart Failure in Pediatrics

3.6.1. Implementation of Medical Management Strategies: Optimal Pharmacotherapy for Heart Failure in Children
3.6.2. Surgical Management: Circulatory Assist Devices and Transplantation
3.6.3. Monitoring and Management of Side Effects and Complications of Heart Failure Treatment 

3.7. Bradyarrhythmias in the Intensive Care Unit

3.7.1. Causes of Bradyarrhythmia in critical pediatric patients
3.7.2. Management of Emergencies Associated with Bradyarrhythmias: Use of Temporary Pacemakers
3.7.3. Continuous Monitoring and ECG Interpretation in the Management of  Bradyarrhythmias 

3.8. Tachyarrhythmias in the Intensive Care Unit

3.8.1. Tachyarrhythmias Based on the Clinical Presentation and ECG Findings in Children
3.8.2. Implementation of Acute Management Protocols for Tachyarrhythmias: Antiarrhythmic Medication and Cardioversion
3.8.3. Long-term Management Planning for Pediatric Patients with Recurrent Tachyarrhythmias

3.9. Hypertension in Pediatrics 

3.9.1. Diagnosis and Evaluation of Hypertension in Children: Identification of Secondary Hypertension
3.9.2. Management of Pediatric Hypertension with Lifestyle Modifications and Pharmacotherapy
3.9.3. Monitoring of the Efficacy and Safety of Therapeutic Interventions in Children with Hypertension

3.10. Thrombosis and Anticoagulation in Pediatrics

3.10.1. Antithrombotic Prophylaxis in the PICU
3.10.2. Treatment of Thrombosis in Pediatrics
3.10.3. Indications for Anticoagulation in Pediatrics

Module 4. Cardiologic Emergencies in the Pediatric Intensive Care Unit 

4.1. Diagnostic Orientation of Congenital Heart Diseases in Pediatric Intensive Care Units

4.1.1. Clinical Presentations of Congenital Heart Disease in PICU
4.1.2. Interpretation of Specific Diagnostic Test Findings for Congenital Heart Disease 
4.1.3. Integration of the Clinical History with Imaging and Laboratory Findings to Establish an Initial Diagnostic Plan 

4.2. Management of Congenital Heart Disease in the ICU

4.2.1. Coordination of the Multidisciplinary Management of Patients with Congenital Heart Disease in the ICU 
4.2.2. Monitoring and Adjustment of Specific Pharmacological Treatment for Each Type of Congenital Heart Disease
4.2.3. Implementation of Strategies to Prevent Complications Associated with Congenital Heart Disease in the ICU 

4.3. Mechanical Circulatory Support

4.3.1. Evaluation of the Indication for Mechanical Circulatory Support in Critical Pediatric Patients
4.3.2. Management of Ventricular Assist Devices Operation and Complications
4.3.3. Monitoring of the Patient's Response to Circulatory Support and Adjustments According to Clinical Evolution

4.4. Cardiac Tamponade

4.4.1. Early Recognition of Signs and Symptoms
4.4.2. Mastery of Diagnostic Techniques for Cardiac Tamponade
4.4.3. Effective Implementation of Emergency Interventions

4.5. Myocarditis and Cardiomyopathies

4.5.1. Signs and Symptoms of Myocarditis and Cardiomyopathies in Children and Young Adults 
4.5.2. Interpretation of Imaging and Laboratory Studies for Diagnostic Confirmation of Myocarditis and Cardiomyopathies 
4.5.3. Implementation of Specific Treatments for Myocarditis and Cardiomyopathies  Management of Heart Failure

4.6. Pericarditis and Pericardial Effusion

4.6.1. Diagnosis of Pericarditis and Pericardial Effusion using Clinical and Echocardiographic Tools
4.6.2. Management of Acute Pericarditis and Pericardial Effusion Pericardiocentesis
4.6.3. Prevention of Long-term Complications of Pericarditis and Pericardial Effusion: Pericardial Constriction

4.7. Postoperative Management of Pediatric Cardiac Surgery

4.7.1. Supervision of Immediate Postoperative Hemodynamic and Respiratory Stabilization
4.7.2. Detection and Treatment of Common Postoperative Complications in Pediatric Cardiac Surgery
4.7.3. Recovery and Rehabilitation: Comprehensive Postoperative Care Plan

4.8. Echocardiography in PICU

4.8.1. Performing and Interpreting Echocardiograms to Guide Real-time Intensive Care Management 
4.8.2. Echocardiography to Monitor Ventricular Function and Assess for the Presence of of Structural Abnormalities
4.8.3. Use of Echocardiography to Assess the Efficacy of Treatment and the Need for Therapeutic Adjustments 

4.9. Vasopressors, Vasodilators and Inotropic Agents in Pediatrics

4.9.1. Selection and Dosing of Vasopressors, Vasodilators and Inotropic Agents for Different Clinical Scenarios
4.9.2. Monitoring of Cardiovascular Response and Adjustment of Pharmacological Therapy According to the Patient's Evolution
4.9.3. Recognition and Management of Side Effects and Drug-drug Interactions of these Agents 

4.10. Basic and Advanced Cardiorespiratory Resuscitation

4.10.1. Performance of Basic Cardiorespiratory Resuscitation in Pediatric Patients:  Application of Chest Compressions and Assisted Ventilation
4.10.2. Advanced Cardiac Life Support Techniques in Children Airway Management, Vascular Access, Drug Administration and Use of Defibrillators
4.10.3. Analysis and Response to the Different Possible Scenarios of Pediatric Cardiac Arrest

Module 5. Neurological Emergencies in the Pediatric Intensive Care Unit

5.1. Management of the Pediatric Patient with Traumatic Brain Injury

5.1.1. Evaluation and Stabilization of Pediatric Patients with Head Trauma Following Current Trauma Protocols
5.1.2. Strategies for Monitoring and Management of Intracranial Pressure in Traumatic Head Injury
5.1.3. Long-term Multidisciplinary Management Plan to Improve Neurological Outcomes after Traumatic Brain Injury in Children

5.2. Seizures and Status Epilepticus in the ICU

5.2.1. Management of Seizures and Status Epilepticus in Critically Ill Pediatric Patients
5.2.2. Electroencephalographic (EEG) Monitoring to Guide the Management of Seizures and Status Epilepticus 
5.2.3. Antiepileptic Treatment of the Pediatric ICU Patient

5.3. Pediatric Stroke

5.3.1. Stroke in Children and Response with Rapid Diagnostic Evaluations
5.3.2. Acute Treatments for Pediatric Ischemic and Hemorrhagic Stroke Based on Current Recommendations
5.3.3. Continuity of Care and Rehabilitation Planning for Pediatric Post-stroke Patients 

5.4. Meningitis and Encephalitis in Children

5.4.1. Early Diagnosis of Meningitis and Encephalitis in Pediatric ICU by using Clinical Protocols and Laboratory Techniques
5.4.2. Administration of Antimicrobial Therapy and Supportive Care for the Treatment of Meningitis and Encephalitis
5.4.3. Monitoring and Management of Short and Long term Complications associated with Meningitis and Encephalitis in Children 

5.5. Intracranial Hypertension Management

5.5.1. Intracranial Hypertension in Pediatric Patients Causes and Clinical Signs
5.5.2. Techniques for Management of Intracranial Hypertension Optimization of Head Position and Pharmacotherapy
5.5.3. Integration of Intracranial Pressure Monitoring in Clinical Decision Making and Treatment Adjustment

5.6. Neurological Monitoring in ICU

5.6.1. Implementation and Analysis of Continuous Neurological Monitoring to Guide Clinical Management: EEG and other Biomarkers
5.6.2. Assessment of Brain Function through Various Monitoring Modalities and Treatment Adjustment
5.6.3. Use of Neurological Monitoring Data for Prevention and Detection of Secondary  Complications in the Pediatric ICU 

5.7. Neuroprotection and Post-resuscitation Care

5.7.1. Neuroprotection Strategies to Minimize Secondary Brain Damage after Events such as Cardiac Arrest 
5.7.2. Management of Temperature Control Therapy and other Post-resuscitation Care to Optimize Neurological Outcomes 
5.7.3. A Multidisciplinary Approach to Rehabilitation and Family Support after Successful Resuscitation

5.8. Neuromuscular Diseases in the ICU

5.8.1. Diagnosis and Management of Acute and Chronic Neuromuscular Diseases in the PICU Setting  
5.8.2. Ventilatory and Nutritional Support for Patients with Neuromuscular Diseases
5.8.3. Long-term Care Coordination and Transition Planning for Children with Neuromuscular Disease Requiring Intensive Care

5.9. Sedation and Analgesia in Neurointensivists

5.9.1. Application of Pharmacology Principles for the Safe and Effective Administration of Sedatives and Analgesics in Critically Ill Pediatric Patients with Neurological  Conditions 
5.9.2. Ongoing Assessment of the Level of Sedation and Pain in Pediatric Patients using Validated Scales to Ensure Appropriate Pain Management and Comfort
5.9.3. Development of Sedation and Sedation Withdrawal Protocols that Minimize the Risk of Delirium and other Side Effects and Promote Optimal Neurologic Recovery 

5.10. Neurological Rehabilitation in the ICU

5.10.1. Implementation of Individualized Early Rehabilitation Programs for Pediatric Patients in the ICU that Address Specific Motor, Cognitive and Emotional Needs
5.10.2. Collaboration with a Multidisciplinary Team, including Physiotherapists and Occupational Therapists, to Integrate Neurological Rehabilitation into the Intensive Care Plan
5.10.3. Regular Assessment and Reporting of Progress in Neurological Rehabilitation, adjusting Treatment Strategies in Accordance with the Patient's Clinical Progress and Recovery Goals

Module 6. Infectious Emergencies and Sepsis in the Pediatric Intensive Care Unit

6.1. Sepsis and Septic Shock in Pediatrics

6.1.1. Diagnostic Criteria for Sepsis and Septic Shock in Pediatric Patients for a Timely and Accurate Diagnosis
6.1.2. Hemodynamic Resuscitation of Children with Septic Shock: Optimizing Tissue Perfusion and Administration of Fluids and Vasopressors
6.1.3. Response to Antimicrobial Therapy in Pediatric Patients with Sepsis and Septic Shock  Adjustment of Therapies according to Culture and Sensitivity Test Results 

6.2. Management of Severe Infections and Antibiotics

6.2.1. Appropriate Selection and Prescription of Antimicrobials in Pediatric Patients with Severe Infections: Local Microbiology, Age and Weight of Patient and Pediatric Pharmacokinetics
6.2.2. Comprehensive Management Strategies for Patients with Serious Infections: Monitoring of Vital Signs, Interpretation of Laboratory Tests and Ongoing Clinical Evaluation
6.2.3. Implementation of Protocols for Appropriate Antimicrobial Use in the PICU: Duration of Treatment and Escalation of Antimicrobials when Necessary

6.3. Opportunistic Infections in ICU

6.3.1. Opportunistic Infections that can Affect Pediatric Patients in the ICU, especially those with Underlying Medical Conditions or Immunosuppression
6.3.2. Design and Implementation of Effective Strategies for Prevention and Control of Opportunistic Infections in the ICU: use of Barrier Measures and Antimicrobial Prophylaxis as Needed
6.3.3. Risk Assessment and Management of Opportunistic Infections in Immunocompromised Patients: Management Strategies According to the Individual Needs of Each Patient

6.4. Nosocomial Infection Prevention and Control

6.4.1. Design and Implementation of Effective Strategies to Prevent Transmission of Nosocomial Infections in the Pediatric ICU: Hand Hygiene, Asepsis and Proper Management of Medical Devices
6.4.2. Infection Prevention Practices in the ICU by Monitoring Infection Rates and of Infection Rates and Identification of Areas for Improvement
6.4.3. Training of Healthcare Personnel and Patient Caregivers on Nosocomial Infection Prevention Measures, Promoting a Culture of Safety and Prevention

6.5. Tropical Diseases in ICU

6.5.1. Recognition and Diagnosis of Tropical Diseases in Pediatric Patients Admitted to the ICU, especially those with a History of Travel to Endemic Areas 
6.5.2. Specific Management Plans for Tropical Diseases: Selection and Administration of Anti-parasitic and Antiviral Treatments
6.5.3. Prevention Strategies to Reduce Patient Exposure to Tropical Diseases in the ICU: Protection Against Vectors and Education to Patients and their Families

6.6. Immunodeficiencies and ICU Management

6.6.1. Clinical Management of Pediatric Patients with Immunodeficiencies Requiring Intensive Care
6.6.2. Management Protocols in the Administration of Immunoglobulins and Prophylaxis of Opportunistic Infections in Patients with Severe Immunodeficiencies
6.6.3. Collaboration with Immunology Specialists to Optimize the Management of Pediatric Immunodeficiency Patients: Planning of Stem Cell Replacement Therapies if Necessary

6.7. Management of the Immunosuppressed Patient

6.7.1. Causes and Degree of Immunosuppression in Pediatric Patients: Patients who have Received Organ Transplantation or Immunosuppressive Therapies to Customize their Clinical Management
6.7.2. Infection Prevention Strategies in Immunosuppressed Patients: Administration of Antimicrobial Prophylaxis and Education on Hygiene Measures and Risk Avoidance
6.7.3. Collaboration with Transplant Teams and Immunology Specialists: Coordination and Supervision of the Comprehensive Care of Immunosuppressed Pediatric Patients in the ICU

6.8. Central Nervous System Infections

6.8.1. Central Nervous System Infections in Pediatric Patients, Meningitis and Encephalitis, by Interpretation of Clinical Findings and Laboratory and Neuroimaging Studies
6.8.2. Development of Specific Management Plans for Patients with Central Nervous System Infections: Choice and Dosage of Antimicrobials and Neurological Support Therapies
6.8.3. Neurological Evolution of Pediatric Patients with Central Nervous System Infections:  Treatment Strategies

6.9. Severe Viral Diseases

6.9.1. Severe Viral Diseases in Pediatric Patients in the ICU: Serious Viral Respiratory Infections and Emerging Viral Diseases
6.9.2. Management of Viral Diseases: Antiviral Administration, Advanced Respiratory Support and Viral Load Monitoring in Critically Ill Patients
6.9.3. Viral Disease Prevention and Control Strategies in the ICU: Application of Isolation Protocols and Protective Measures for Medical and Nursing Staff

6.10. Isolation Protocols and Barriers

6.10.1. Isolation Protocols in the Pediatric ICU to Prevent the Transmission of Infectious Diseases: Route of Transmission, Duration of Isolation and Specific Precautions 
6.10.2. Isolation Measures and Appropriate use of Personal Protective Equipment (PPE) to Minimize the Risk of Infection
6.10.3. Evaluating the Effectiveness of Isolation Protocols and Making Adjustments to Improve Patient Safety

Module 7. Digestive, Renal, and Neurosurgical Emergencies in the Pediatric Intensive Care Unit 

7.1. Assessment and Monitoring of the Nutritional Situation and Calculation of Nutritional Needs Enteral and Parenteral Nutrition in the Critically Ill Child

7.1.1. Nutritional Status and Calculation of Nutritional Needs
7.1.2. Enteral Nutrition
7.1.3. Parenteral Nutrition

7.2. Major Burns and their Management in the ICU

7.2.1. Diagnosis of % scq
7.2.2. Calculation of Water Needs
7.2.3. Need for Mechanical Ventilation in Large Burn Injuries

7.3. Diabetes Insipidus, Syndrome of Inadequate Antidiuretic Hormone Secretion and Brain Salt Loss Syndrome

7.3.1. Adequate Fluid Management
7.3.2. Differential
7.3.3. Specific Treatment of Diabetes Insipidus, Syndrome of Inadequate Antidiuretic Hormone Secretion and Brain Salt Loss Syndrome.

7.4. Pain Management in Pediatrics

7.4.1. Assessment of Pain in the Critically Ill Child Pain Scales
7.4.2. Pain 5th Constant in Pediatrics
7.4.3. Zero Pain Protocol

7.5. Thrombotic Microangiopathy Uremic-Hemolytic Syndrome

7.5.1. Thrombi in Children
7.5.2. Small Vessel Thrombi
7.5.3. Management of Uremic-haemolytic Syndrome in Critically Ill Children

7.6. Post Renal Transplant Critical Care

7.6.1. Indications for TX in Children
7.6.2. Evaluation of the Recipient
7.6.3. Management of Renal TX in PICU

7.7. Hemorrhage and Transfusion Management

7.7.1. Critical Bleeding
7.7.2. Patient Assessment
7.7.3. Transfusion Management in the Critical Child

7.8. Childhood Stroke

7.8.1. Diagnosis of Stroke in Children
7.8.2. Multidisciplinary Assessment of the Child with Clinical Suspicion of Stroke
7.8.3. Treatment of Stroke

7.9. Neuromonitoring in Critically Ill Patients

7.9.1. Neuromonitoring in Critical Patients
7.9.2. Available Resources
7.9.3. Assessment of Critical Neuromonitoring

7.10. Difficult Airway Postoperative Period

7.10.1. Indications for EC in VAD
7.10.2. VAD Coagulation
7.10.3. Postoperative Management of VAD

Module 8. Toxicology and Endocrinology in the Pediatric Intensive Care Unit

8.1. Diabetic Ketoacidosis

8.1.1. Underlying Causes of Diabetic Ketoacidosis
8.1.2. Diagnosis of Diabetic Ketoacidosis by Interpretation of Clinical Symptoms and Laboratory Results
8.1.3. Effective Treatment Strategies: Management and Prevention of Diabetic Ketoacidosis in Patients with Diabetes 

8.2. Electrical Trauma Injuries

8.2.1. Types of Electrical Trauma Injuries according to Mechanism of Action and Severity
8.2.2. Immediate and Long-term Signs and Symptoms Associated with Electrical Trauma Injuries 
8.2.3. First Aid and Medical Treatment Protocols for Victims of Electrical Trauma

8.3. Alterations in Water-electrolyte Metabolism

8.3.1. Functions of the Main Electrolytes in the Body Importance for Water-electrolyte Balance
8.3.2. Common Causes and Clinical Signs of Disturbances in Water-Electrolyte Balance
8.3.3. Management of Disturbances in Water-electrolyte Metabolism by Appropriate Therapeutic Interventions

8.4. Acute Adrenal Insufficiency

8.4.1. Risk Factors and Precipitating Causes of Acute Adrenal Insufficiency 
8.4.2. Characteristic Clinical Signs and Symptoms of Acute Adrenal Insufficiency for Early Diagnosis
8.4.3. Urgent Management Strategies for the Treatment of Acute Adrenal Insufficiency: Cortisol Replenishment

8.5. Disorders of the Thyroid Gland

8.5.1. Disorders of the Thyroid Gland, Hypothyroidism and Hyperthyroidism: Clinical Features and Laboratory Findings
8.5.2. Clinical Implications of Autoimmune Thyroid Disorders: Disease and Hashimoto's Thyroiditis on the Physiology and Well-being of the Patient
8.5.3. Diagnostic and Therapeutic Approach to Thyroid Disorders: Medical, Surgical Treatment and the Management of Complications

8.6. Inhalation Injuries

8.6.1. Types of Inhalation Injuries: Thermal, Chemical and Smoke Inhalation Injuries and their Mechanisms of Injury 
8.6.2. Immediate and Long-term Signs and Symptoms Associated with Inhalation Injuries: Early and Accurate Diagnosis
8.6.3. Treatment and Management Strategies for Patients with Inhalation Injuries: Respiratory Support and Specific Therapies for Toxic Agents

8.7. Inherited Metabolic Diseases

8.7.1. Principles of Genetics and Inheritance of Metabolic Diseases with Identification of Commonly Affected Metabolic Pathways
8.7.2. Clinical Signs and Symptoms of the Inherited Metabolic Diseases: Early Diagnosis
8.7.3. Management Strategies and Specific Treatment for Inherited Metabolic Diseases: Special Diets, Enzyme Supplementation and Gene Therapies

8.8. Antidotes and their Use in Pediatrics

8.8.1. Specific Antidotes in Pediatrics for the most Common Intoxications: Mechanisms of Action
8.8.2. Indications, Dosage and Routes of Administration of Antidotes in the Management of Acute Poisonings in Children
8.8.3. Protocols of Action in Emergency Situations with the Use of Antidotes: Pharmacokinetic and Pharmacodynamic Particularities in the Pediatric Population

8.9. Carbon Monoxide Poisoning

8.9.1. Pathophysiology of Carbon Monoxide Poisoning: how it Affects the Body Focusing on its High Affinity for Hemoglobin and the Resulting Systemic Effects
8.9.2. Clinical Signs and Symptoms of Carbon Monoxide Poisoning: Acute and Potential Long-term Neurological and Cardiovascular Health Effects 
8.9.3. Treatment Strategies for Carbon Monoxide Poisoning: Administration of 100% Oxygen and Hyperbaric Therapy in Appropriate Cases

8.10. Acute Poisoning

8.10.1. Toxic Agents Responsible for Acute Poisoning: Drugs, Industrial and Household Chemicals and Natural Toxins
8.10.2. Clinical Signs and Symptoms associated with Acute Intoxications for Rapid and Accurate Diagnosis
8.10.3. Initial Management of Acute Poisonings: Stabilization of the Patient, Decontamination Techniques and Administration of Specific Antidotes when Indicated

Module 9. Neonatal Intensive Care

9.1. Neonatal Intensive Care

9.1.1. Immediate Life Support Measures in Neonates
9.1.2. Thermoregulation Management in the NICU
9.1.3. Prevention of Nosocomial Infections in Neonates

9.2. Oxygen Therapy and Noninvasive Ventilation in the NB

9.2.1. Oxygen Therapy: Adjustment of Oxygen Concentrations
9.2.2. Noninvasive Ventilation Techniques for Different Neonatal Conditions
9.2.3. Monitoring and Prevention of Complications Related to Oxygen Therapy and  Noninvasive Ventilation 

9.3. Enteral Nutrition in the Sick NB

9.3.1. Criteria for Initiation and Progression of Enteral Nutrition
9.3.2. Management of Complications of Enteral Feeding in Sick Neonates
9.3.3. Adaptation of Enteral Nutrition Regimens According to the Specific Needs of the Sick NB 

9.4. Parenteral Nutrition in NICU

9.4.1. Formulation of Parenteral Nutrition Mixtures According to the Individual Requirements of the NB
9.4.2. Monitoring the Efficacy and Safety of Parenteral Nutrition: Prevention of Complications 
9.4.3. Protocols for Transition from Parenteral to Enteral Nutrition

9.5. Screening and Management of the NB with Suspected Congenital Heart Disease

9.5.1. Neonatal Screening Strategies for Congenital Heart Disease
9.5.2. Clinical Signs and Diagnostic Findings in Neonatal Cardiopathies
9.5.3. Initial Management of Neonates with Congenital Heart Disease

9.6. Management of the Newborn (NB) with Suspected Infection Newborn with Septic Shock

9.6.1. Early Signs of Infection and Septic Shock in Neonates
9.6.2. Application of Empirical and Supportive Antimicrobial Management Protocols in Septic Shock
9.6.3. Monitoring of the Response to Treatment and Adjustment of Management according to Clinical Evolution

9.7. Pain and Stress Management in the NICU

9.7.1. Assessment of Pain and Stress in Neonates using Validated Scales
9.7.2. Implementation of Pharmacological and Non-pharmacological Measures for Pain and Stress Management 
9.7.3. Strategies for the Minimization of Pain and Stress during Invasive Procedures

9.8. General Management of the Extreme Preterm Newborn (ELN)

9.8.1. Specific Respiratory and Nutritional Support Strategies for the Extreme Preterm Newborn 
9.8.2. Prevention and Management of Complications Associated with Extreme Prematurity
9.8.3. Implementation of Developmental Care and Family Support in the Management of the Extreme Preterm NB 

9.9. Management of the Most Frequent Hydroelectrolyte Disorders of the NB Neonatal Hypoglycemia

9.9.1. Treatment of Electrolyte Imbalances in Neonates
9.9.2. Diagnosis and Management of Neonatal Hypoglycemia according to Current Guidelines
9.9.3. Monitoring and Adjustment of Fluid and Electrolyte Management in Response to Clinical and Laboratory Changes  

9.10. Severe Hyperbilirubinemia of the NB Exchange Transfusion

9.10.1. Identification of Risk Factors and Signs of Severe Hyperbilirubinemia
9.10.2. Application of Protocols for the Treatment of Hyperbilirubinemia  Phototherapy and Exchange Transfusion
9.10.3. Prevention of Long-term Complications Associated with Severe Hyperbilirubinemia Treatment

Module 10. Advanced Aspects in Neonatal Intensive Care Index

10.1. Hemodynamic Management of the Sick NB Severe PHT in the NB

10.1.1. Signs of Hemodynamic Instability and PHT in the NB
10.1.2. Hemodynamic Management Strategies including Inotropic Support and Management of PHT
10.1.3. Monitoring of the Response to Treatment and Adjustment according to the Clinical Evolution of the NB

10.2. Neonatal Mechanical Ventilation Conventional MV VAFO

10.2.1. Indications for Conventional Mechanical Ventilation and High Frequency Oscillatory  Ventilation (HFOV)
10.2.2. Adjustment of Ventilation Parameters to Optimize Oxygenation and Ventilation while Minimizing the Risk of Lung Injury 
10.2.3. Monitoring and Management of Complications Associated with Mechanical Ventilation 

10.3. Management of Hyaline Membrane Disease (HMD)

10.3.1. Identification of Risk Factors and Clinical Signs of HME in the NB
10.3.2. Management Strategies including Respiratory Support and Surfactant Administration 
10.3.3. Evaluation of Response to Treatment and Prevention of Complications Associated with HME 

10.4. Newborn (NB) with Congenital Diaphragmatic Hernia (CDH)

10.4.1. Clinical Presentation and Diagnosis of CDH
10.4.2. Management including Respiratory Support and Preoperative Hemodynamic Stabilization
10.4.3. Surgical Management and Specific Postoperative Care for NB with CDH 

10.5. Management of the NB with Perinatal Asphyxia

10.5.1. Identification and Classification of the Severity of Perinatal Asphyxia 
10.5.2. Life Support Interventions and Management of Therapeutic Hypothermia if Indicated 
10.5.3. Monitoring of Neurological Sequelae and other Complications Associated with Perinatal Asphyxia   

10.6. Neurological Disorders in the Newborn (NB) Requiring NICU

10.6.1. Early Signs of Neurological Disorders in the Newborn
10.6.2. Strategies for Neurological Evaluation and Management of Specific Neurological Conditions 
10.6.3. Multidisciplinary Care for the Comprehensive Management of Neurological Disorders 

10.7. Severe Metabolic Diseases in the Newborn (NB)

10.7.1. Clinical and Laboratory Signs Suggestive of Severe Metabolic Diseases
10.7.2. Acute Management of Metabolic Decompensation and Specific Diagnostic Tests
10.7.3. Implementation of Long-term Management Plans and Follow-up for Diagnosed Metabolic Conditions 

10.8. Most Common Neonatal Surgical Pathology Postoperative Care

10.8.1. Surgical Indications in Common Neonatal Pathologies
10.8.2. Implementation of Preoperative Care and Preparation for Neonatal Surgeries
10.8.3. Specific Postoperative Care to Optimize Recovery and Prevent Complications

10.9. Management of Necrotizing Enterocolitis (NEC)

10.9.1. Identification of Early Signs and Risk Factors for NEC 
10.9.2. Application of Conservative Management Protocols and Criteria for Surgical  Intervention
10.9.3. Monitoring Recovery and Management of Long-term Complications of NEC 

10.10. Critical Neonatal Transport 

10.10.1. Preparation of the Critically Ill Newborn for Safe Transport: Stabilization and Life Support  
10.10.2. Coordination of Logistics and Effective Team Communication for Neonatal Transport 
10.10.3. Monitoring and Management of the NB during Transport: Prevention and Response to Complications

Make the most of this opportunity to surround yourself with expert professionals and learn from their work methodology"